UK PM Starmer China Visit
Analysis based on 9 articles · First reported Jan 30, 2026 · Last updated Feb 01, 2026
The visit by Keir Starmer to China, resulting in trade and visa agreements, is expected to boost the United Kingdom's economic growth and increase British exports, particularly for industries like Whisky. AstraZeneca's $15 billion investment in China signals strong confidence in the Chinese pharmaceutical market, while Pop Mart's expansion into the United Kingdom and Europe indicates growing trade ties.
British Prime Minister Keir Starmer undertook a four-day diplomatic visit to China, the first by a British prime minister in eight years, aimed at strengthening economic and diplomatic ties. During his trip, Starmer met with Chinese President Xi Jinping and Premier Li Qiang, where both sides emphasized the need for closer relations. Key outcomes included China agreeing to visa-free travel for British passport holders for stays under 30 days and a reduction of tariffs on British Whisky from 10% to 5%. Agreements were also signed on cooperation against migrant smugglers, British exports, health, and strengthening a bilateral trade commission. The visit occurred despite warnings from US President Donald Trump, who called closer UK-China business ties 'very dangerous'. British pharmaceutical giant AstraZeneca announced a $15 billion investment in China through 2030, and Chinese company Pop Mart revealed plans to establish a regional hub in London and open new stores across Europe. Starmer's trip is seen as part of a broader Western effort to counter a volatile United States and boost the United Kingdom's economic growth.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard